# Characterizing Human Oxidative, Anabolic and Glycolytic Metabolism in Athletes with Extreme Physiologies

**Authors:** Daniela Schranner, Henning Wackerhage, Patrick Weinisch, Jürgen Schlegel, Stephanie Bremer, Johannes Scherr, Werner Römisch-Margl, Annett Riermeier, Otto Zelger, Fabian Stöcker, Anna Artati, Michael Witting, Jan Krumsiek, Martin Halle, Martin Schönfelder, Gabi Kastenmüller

PMC · DOI: 10.1186/s40798-026-00989-z · Sports Medicine - Open · 2026-03-09

## TL;DR

This study compares the blood metabolomes of athletes with different training backgrounds to understand how exercise shapes human metabolism.

## Contribution

The paper identifies distinct metabolic signatures in endurance athletes, sprinters, and bodybuilders, revealing how specialized training alters serum metabolites.

## Key findings

- Endurance athletes showed higher phospholipid levels, indicating oxidative metabolism adaptations.
- Bodybuilders had lower sulfated steroids, reflecting anabolic metabolism traits.
- Sprinters exhibited lower sphingomyelin levels, suggesting glycolytic metabolism adaptations.

## Abstract

Regular physical activity is known to benefit health but the long-term effects of specific exercise training on human metabolism remain incompletely described. In this study, we comprehensively characterized the blood metabolomes of male athletes with distinct exercise-adapted metabolic profiles, comparing endurance athletes (n = 11), sprinters (n = 8), and natural body builders (n = 9) as models for highly oxidative, glycolytic, and anabolic metabolism, respectively.

Serum samples of these athletes and a control group of male untrained individuals (n = 7) were collected both at rest and after maximum exercise. Using untargeted metabolomics profiling and weighted correlation network analysis, we examined associations of metabolites and metabolite modules with athlete groups and their characteristic traits (e.g., cardiovascular fitness or muscularity).

Our analyses revealed distinct metabolic signatures for the different groups: a highly anabolic metabolism was characterized by lower levels of sulfated steroids; a highly oxidative metabolism by higher levels of phospholipids; and a highly glycolytic metabolism by lower levels of sphingomyelins. In response to maximum exercise, 130 metabolites changed across all groups (e.g., N-lactoyl amino acids, acylcholines, energy metabolites), while 57 metabolites showed differences in magnitude or direction of change between groups (e.g., fatty acid oxidative products, cortisol).

Our findings demonstrate that exercise-induced adaptations in metabolism distinctly shape the human serum metabolome and influence the metabolic response to exercise. These insights are relevant for diseases driven by dysfunctional metabolism, such as impaired fat oxidation and dysregulated glycolysis (e.g., diabetes, dementia) and muscle wasting (e.g., sarcopenia), where our specialized populations may serve as useful models.

The online version contains supplementary material available at 10.1186/s40798-026-00989-z.

We deeply characterized and compared the serum metabolome (quantification of ≈850 metabolites) of endurance athletes, natural bodybuilders, sprinters, and untrained controls at rest and in response to maximum exercise.Specialized long-term training leads to metabolic adaptations in sulfated steroids (bodybuilders), phospholipids (endurance athletes), or sphingolipids (sprinters).Regardless of training history, energy metabolites and N-lactoyl amino acids increase after all-out exercise.Fifty-seven metabolites changed differently in response to exercise between the athlete groups, highlighting their different metabolic capabilities under physical stress.

We deeply characterized and compared the serum metabolome (quantification of ≈850 metabolites) of endurance athletes, natural bodybuilders, sprinters, and untrained controls at rest and in response to maximum exercise.

Specialized long-term training leads to metabolic adaptations in sulfated steroids (bodybuilders), phospholipids (endurance athletes), or sphingolipids (sprinters).

Regardless of training history, energy metabolites and N-lactoyl amino acids increase after all-out exercise.

Fifty-seven metabolites changed differently in response to exercise between the athlete groups, highlighting their different metabolic capabilities under physical stress.

The online version contains supplementary material available at 10.1186/s40798-026-00989-z.

## Linked entities

- **Diseases:** diabetes (MONDO:0005015), dementia (MONDO:0001627)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** PCSK1 (proprotein convertase subtilisin/kexin type 1) [NCBI Gene 5122] {aka BMIQ12, NEC1, PC1, PC1/3, PC3, SPC3}, STS (steroid sulfatase) [NCBI Gene 412] {aka ARSC, ARSC1, ASC, ES, SSDD, XLI}, PLA2G1B (phospholipase A2 group IB) [NCBI Gene 5319] {aka PLA2, PLA2A, PPLA2}, PC (pyruvate carboxylase) [NCBI Gene 5091] {aka PCB}, PLA2G2A (phospholipase A2 group IIA) [NCBI Gene 5320] {aka MOM1, PLA2, PLA2B, PLA2L, PLA2S, PLAS1}, SULT2A1 (sulfotransferase family 2A member 1) [NCBI Gene 6822] {aka DHEA-ST, DHEA-ST8, DHEAS, HST, ST2, ST2A1}, BCHE (butyrylcholinesterase) [NCBI Gene 590] {aka BCHED, CHE1, CHE2, E1}
- **Diseases:** type 2 diabetes (MESH:D003924), muscular damage (MESH:D009135), dementia (MESH:D003704), cardiovascular diseases (MESH:D002318), myocardial ischemia (MESH:D017202), hyperglycemic (MESH:D006944), impaired glucose &amp; lipid metabolism (MESH:D052439), RP (MESH:D000210), obesity (MESH:D009765), CPET (MESH:D013736), stroke (MESH:D020521), AD (MESH:D000544), Diabetes (MESH:D003920), CNS (central nervous system) diseases (MESH:D002493), neurodegenerative and metabolic diseases (MESH:D019636), sarcopenia (MESH:D055948), inflammatory (MESH:D007249), muscle damage (MESH:D009133), Lyso-PC (MESH:D015324), Mitochondrial Disorders (MESH:D028361), disrupted muscle growth (MESH:D006130)
- **Chemicals:** Sphingolipids (MESH:D013107), Lysophosphatidylcholines (MESH:D008244), glucose (MESH:D005947), hexanoylcarnitine (MESH:C061301), 4-methyl-2-oxopentanoate (MESH:C013082), PE (MESH:D010714), Steroid hormones (MESH:D013256), DHA (MESH:D004281), pregnenolone sulfate (MESH:C018370), lipid (MESH:D008055), purine (MESH:C030985), N-lactoyl phenylalanine (MESH:C000723769), myristoylcarnitine (MESH:C538774), 1,5-anhydroglucitol (MESH:C006584), PFPA (MESH:C000619812), amino acids (MESH:D000596), ammonium bicarbonate (MESH:C027043), TCA (MESH:D014238), Acylcarnitines (MESH:C116917), chenodeoxycholate (MESH:D002635), PC (MESH:C053518), Phosphatidylcholines (MESH:D010713), fatty acid (MESH:D005227), carbohydrate (MESH:D002241), 1,5-AG (-), Sphingomyelins (MESH:D013109), Bile acid (MESH:D001647), palmitoyl dihydrosphingomyelin (MESH:C401300), glycerol (MESH:D005990), BCAA (MESH:D000597), Lyso-PC (MESH:C006065), xanthine (MESH:D019820), malate (MESH:C030298), Dicarboxylic acid (MESH:D003998), Ceramides (MESH:D002518), palmitoyl sphingomyelin (MESH:C033171), androsterone (MESH:D000738), water (MESH:D014867), Phospholipids (MESH:D010743), EPA (MESH:D015118), SM (MESH:D012493), glycochenodeoxycholate 3-sulfate (MESH:C038329), peptides (MESH:D010455), nucleotides (MESH:D009711), testosterone (MESH:D013739), acetylcholine (MESH:D000109), Cysteine Sulfinic Acid (MESH:C013461), lactate (MESH:D019344), omega-3 fatty acids (MESH:D015525), AC (MESH:D000186), Cortisol (MESH:D006854), butyrylcarnitine (MESH:C427065), acetonitrile (MESH:C032159), pregnenolones (MESH:D011284), carbons (MESH:D002244), inosine (MESH:D007288), pyruvate (MESH:D019289), Fat (MESH:D005223), succinate (MESH:D019802), methanol (MESH:D000432)
- **Species:** Homo sapiens (human, species) [taxon 9606], Athletes (genus) [taxon 1337349], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** rs10426201

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12972380/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12972380/full.md

---
Source: https://tomesphere.com/paper/PMC12972380